11/15
Cancer Research
Easing patient fears of radiation treatment, via virtual reality
Easing patient fears of radiation treatment, via virtual reality
Before their first dose of radiation, cancer patients can shadow another patient’s treatment and get a private behind-the-scenes tour with the team members via virtual reality.
White House names Abramson Cancer Center neuro-oncologist a Cancer Moonshot Scholar
White House names Abramson Cancer Center neuro-oncologist a Cancer Moonshot Scholar
Richard E. Phillips, chief of the division of Neuro-Oncology and an assistant professor of neurology, is among 11 scholars included in this year’s cohort, who will support cancer research and innovation across the country.
Combo immunotherapy produces distinct waves of cancer-fighting T cells
Combo immunotherapy produces distinct waves of cancer-fighting T cells
Researchers from Penn’s Abramson Cancer Center have found that a novel tool that tracks immune health over time has revealed new insights on immune cell activation.
Understanding the cellular mechanisms driving solid tumors’ robust defense system
Understanding the cellular mechanisms driving solid tumors’ robust defense system
Researchers from Penn have identified a “forcefield-like” defense system in solid tumors and the genetic elements that can switch it off.
A modified peptide shows promise for fighting tumors
A modified peptide shows promise for fighting tumors
Researchers in Penn Vet led a collaborative study that demonstrates how a modified peptide normalizes tumor vasculature and enhances various cancer treatments.
Improving care for patients with acute lymphocytic leukemia
Improving care for patients with acute lymphocytic leukemia
How one Penn Medicine patient’s role in a clinical trial for acute lymphocytic leukemia therapy brought a cancer-free diagnosis and FDA approval.
A newly identified immune checkpoint protein may lead to future cancer therapies
A newly identified immune checkpoint protein may lead to future cancer therapies
Penn Medicine researchers have found that knocking out a T cell’s CD5 gene greatly enhances the cell’s anticancer activity in a variety of preclinical cancer models.
Penn pioneers a ‘one-pot platform’ to promptly produce mRNA delivery particles
Penn pioneers a ‘one-pot platform’ to promptly produce mRNA delivery particles
New lipid platform enables rapid synthesis of molecules that can shuttle therapeutics for a range of diseases with a high degree of organ specificity.
The power of protons
The power of protons
Penn Medicine has treated more than 10,000 cancer patients at three proton therapy centers across the region, including the largest and busiest center in the world—while also leading the way in research to expand the healing potential of these positive particles.
Slowing inflammation may boost immunotherapy’s effectiveness against advanced lung cancer
Slowing inflammation may boost immunotherapy’s effectiveness against advanced lung cancer
Patients with stage 4 lung cancer show high response rates after an anti-inflammatory drug is added temporarily to immune checkpoint inhibitor therapy.
In the News
Forbes
Carl June: 2024 will be seen as a breakthrough year for brain cancer
Carl June of the Perelman School of Medicine shares five insights on using CAR T cell therapy to combat cancer, featuring remarks from Bruce Levine.
FULL STORY →
Philadelphia Inquirer
Penn plans to build a proton center for cancer treatment at Presbyterian Medical Center
Penn Medicine will build its fourth proton beam center for cancer treatment at Penn Presbyterian Medical Center in University City.
FULL STORY →
PhillyVoice
Double mastectomies do not improve breast cancer survival likelihood for most women, study finds
Angela DeMichele of the Perelman School of Medicine says that chemotherapy and hormonal therapies are important for combating breast cancer because they’re designed to kill spreading cells.
FULL STORY →
The New York Times
Breast cancer survival not boosted by double mastectomy, study says
Angela DeMichele of the Perelman School of Medicine comments on a study which found that breast cancer survival is not boosted by a double mastectomy.
FULL STORY →
Today
How did Shannen Doherty die? What to know about ‘90210’ star’s cause of death
According to Penn Medicine, there is no known cure for metastatic breast cancer.
FULL STORY →
Stat
New immunotherapy combination could ‘change the landscape’ of cancer treatment
A study by Andy Minn and postdoc Divij Mathew of the Perelman School of Medicine and colleagues found that a combination checkpoint inhibitor therapy benefited patients with lung cancer.
FULL STORY →